semaglutide clearance A higher-dose of Wegovy has received final regulatory in the EU, marking a significant step for obesity treatment. The approval allows physicians to prescribe a weekly 7.2 mg dose, administered as Spotlight on the Mechanism of
Description
For example, patients with specific GLP1R variants may experience robust appetite suppression at lower doses, while others require closer to maximum doses to feel the medication's effects

This is not a one-size-fits-all therapy
Dehydration + less chewing less saliva Reflux or vomiting acid exposure Nutrient gaps weaker enamel and gums Facial and jaw changes faster than dental adaptation What It All Means GLP1s help but your mouth might need backup

Rising drug budgets are tightening formularies and prior authorization processes, as overall prescription drug spending is expected to increase by 9.0-11.0% in 2025
Tirzepatide resulted in an average weight loss of 20.9% of body weight, making it one of the most effective medications available for weight management

Medication-specific characteristics also matter
